Ramal Weragoda, MD
Clinical Cardiac Electrophysiology · Canton, GANPI 1679899074
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (38.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Medtronic at 45.8% of the total. 2025 is the largest year on record at $7,813, 4.0 times the $1,970 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in GA, where the typical reported total is $21,716.
Across 223 payments — averaging $108.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Abbott$9K
- Boston Scientific$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$327
- Pfizer$283
- Novartis$223
- plus $2K from 23 others
What the payments were for
- Consulting fees$7003%
- Speaking & faculty fees$5,96925%
- Travel & lodging$9,41539%
- Food & beverage$8,19034%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 44 | $11,120 |
| Abbott | 71 | $8,650 |
| Boston Scientific | 17 | $1,938 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $327 |
| Pfizer | 15 | $283 |
| Novartis | 11 | $223 |
| E.r. Squibb & Sons, L.L.C. | 8 | $217 |
| Esperion Therapeutics, Inc. | 4 | $151 |
| Janssen Scientific Affairs, LLC | 1 | $133 |
| Shockwave Medical, Inc | 1 | $129 |
| Atricure, Inc. | 2 | $127 |
| Boehringer Ingelheim | 7 | $124 |
| Edwards Lifesciences | 2 | $111 |
| Biosense Webster, Inc. | 2 | $109 |
| Heartflow, Inc. | 1 | $107 |
| Johnson & Johnson | 6 | $87 |
| Abiomed | 4 | $80 |
| Sanofi-aventis U.S. LLC | 4 | $67 |
| Cvrx, Inc. | 3 | $63 |
| Amgen | 2 | $34 |
| Cardiva Medical, Inc. | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Altathera Pharmaceuticals LLC | 1 | $27 |
| Innovation Technologies Inc | 1 | $26 |
| Artivion, Inc. | 1 | $21 |
| Nuwellis, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $14 |
| Biotronik Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$2,838
- AMPLATZER AMULET$837
- Accent Pacemaker$700
- ENSITE PRECISION$601
- Cardiovascular- Research only$510
- Ensite Cardiac Mapping System$434
- Micra$389
- ENSITE$326
- AFFERA MAPPING SYSTEM$309
- SPHERE-9$192
- Azure$180
- Reveal LINQ$145
- XARELTO$133
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$129
- EPI-SENSE GUIDED COAGULATION SYS$116
- WATCHMAN FLX$109
- Rhythmia Mapping System$107
- FFRct$107
- AZURE XT DR MRI SURESCAN$105
- NA$102
How this compares
$24,274 in reported general payments places this provider in the 50th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 552 | $646,246 |
| XareltoRivaroxaban | 183 | $206,909 |
| EntrestoSacubitril/Valsartan | 24 | $36,755 |
| JardianceEmpagliflozin | 21 | $28,536 |
| MultaqDronedarone Hcl | 18 | $28,528 |
| FarxigaDapagliflozin Propanediol | 19 | $14,695 |
| Dofetilide | 25 | $6,107 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 25 | $5,872 |
| SotalolSotalol Hcl | 331 | $5,754 |
| Metoprolol Succinate | 380 | $5,665 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 94 | $3,344 |
| Flecainide Acetate | 92 | $3,326 |
| Propafenone Hcl ErPropafenone Hcl | 16 | $3,042 |
| ClopidogrelClopidogrel Bisulfate | 171 | $1,255 |
| Metoprolol Tartrate | 111 | $1,069 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $283 | $646,246552 claims |
| Johnson & JohnsonXarelto | $87 | $206,909183 claims |
| NovartisEntresto | $223 | $36,75524 claims |
| Boehringer IngelheimJardiance | $124 | $28,53621 claims |
| Sanofi-aventis U.S. LLCMultaq | $67 | $28,52818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Canton
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- David NewtonSavannah$225K
- Michael LloydAtlanta$221K
- Kent NilssonAthens$198K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
- Alok GambhirGainesville$146K
- Joseph PokuMacon$130K
- Anand KeniaDalton$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.